Coronavirus [COVID-19] – WHO Public Health Emergency of International Concern (PHEIC)

Milestones :: Perspectives :: Research


Coronavirus [COVID-19] – WHO
Public Health Emergency of International Concern (PHEIC)


Weekly Epidemiological and Operational updates
Last update: 18 Jun 2021
Confirmed cases :: 179 686 071 [week ago: 177 108 695]
Confirmed deaths :: 3 899 172 [week ago 3 840 223]
Vaccine doses administered: 2 624 733 776 [week ago: 2 378 482 776]



Weekly operational update on COVID-19 – 22 June 2021
In this edition of the COVID-19 Weekly Operational Update, highlights of country-level actions and WHO support to countries include:
:: Shipment of medical kits to support essential health services in Afghanistan
:: Risk Communication and Community Engagement training for frontline responders in Kyrgyzstan
:: Support as COVID-19 cases surge in Africa, nearing first wave peak
:: Release of Basic Psychosocial Skills online course for Pacific COVID-19 responders
:: Infodemic management training in the Democratic Republic of the Congo to support COVID-19 vaccine rollout
:: Launch of an updated COVID-19 National Rapid Response Teams Online Learning Programme and mixed modality trainings in Guinea-Bissau
:: Progress on a subset of indicators from the SPRP 2021 Monitoring and Evaluation Framework
:: Updates on WHO’s financing to support countries in SPRP 2021 implementation and provision of critical supplies.
Weekly epidemiological update on COVID-19 – 22 June 2021
Global numbers of cases and deaths continued to decrease over the past week (14-20 June 2021) with just over 2.5 million new weekly cases and over 64 000 deaths, a 6% and a 12% decrease respectively, compared to the previous week. While the number of cases reported globally now exceeds 177 million, the lowest weekly case incidence since February 2021 was reported last week. Globally, mortality remains high with more than 9000 deaths reported each day over the past week, however, the number of new deaths reported in the past week decreased across all Regions except for the Eastern Mediterranean and the African Regions.
In this edition, a special focus update is provided on SARS-CoV-2 Variants of Interest (VOIs) and Variants of Concern (VOCs) Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), and Delta (B.1.617.2). This includes updates on emerging evidence surrounding the phenotypic characteristics of VOCs (transmissibility, disease severity, risk of reinfection, and impacts on diagnostics and vaccine performance), as well as updates on the geographic distribution of VOCs.
This edition also includes a summary of a Global Consultation on SARS-CoV-2 Variants of Concern and their Impact on Public Health Interventions.


Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 26 June 2021
For 22 vaccine candidates, presents Manufacturer, Name of Vaccine, NRA of Record, Platform, EOI Accepted Status, Pre-submission Meeting Held Status, Dossier Accepted for Review, Status of Assessment; Anticipated/Completed Decision Date
[No update posted from 16 June 2021 data below; click on the link above for full scale view]